Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
RESEARCH TOOLSreports
Holding LIPO?
Track your performance easily
LIPO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.21 - $12.00
Previous Close$2.63
Volume89.73K
Average Volume (3M)162.85K
Market Cap
$3.18M
Enterprise Value$1.90M
Total Cash (Recent Filing)$1.35M
Total Debt (Recent Filing)$70.83K
Price to Earnings (P/E)―
Beta-1.00
Next Earnings
May 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.50
Shares Outstanding1,208,919
10 Day Avg. Volume210,133
30 Day Avg. Volume162,847
Standard Deviation0.27
R-Squared0.00182
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)1.99
Price to Sales (P/S)6.23
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.92
Enterprise Value/Gross Profit-0.73
Enterprise Value/Ebitda-0.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lipella Pharmaceuticals, Inc. News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LIPO FAQ
What was Lipella Pharmaceuticals, Inc.’s price range in the past 12 months?
Lipella Pharmaceuticals, Inc. lowest stock price was $2.21 and its highest was $12.00 in the past 12 months.
What is Lipella Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Lipella Pharmaceuticals, Inc.’s upcoming earnings report date?
Lipella Pharmaceuticals, Inc.’s upcoming earnings report date is May 15, 2023 which is 561 days ago.
How were Lipella Pharmaceuticals, Inc.’s earnings last quarter?
Lipella Pharmaceuticals, Inc. released its earnings results on Mar 31, 2023. The company reported -$1.487 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.487.
Is Lipella Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Lipella Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Lipella Pharmaceuticals, Inc. pay dividends?
Lipella Pharmaceuticals, Inc. does not currently pay dividends.
What is Lipella Pharmaceuticals, Inc.’s EPS estimate?
Lipella Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lipella Pharmaceuticals, Inc. have?
Lipella Pharmaceuticals, Inc. has 1,208,919 shares outstanding.
What happened to Lipella Pharmaceuticals, Inc.’s price movement after its last earnings report?
Lipella Pharmaceuticals, Inc. reported an EPS of -$1.487 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.622%.
Which hedge fund is a major shareholder of Lipella Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in LIPO
---
Lipella Pharmaceuticals, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.11%
12-Months-Change
Fundamentals
Return on Equity
-231.67%
Trailing 12-Months
Asset Growth
-23.97%
Trailing 12-Months
Company Description
Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company's lead product includes LP-10 and LP-310.
---
LIPO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Enveric Biosciences
―
Cyclacel Pharmaceuticals
―
Aditxt, Inc.
―
Sonoma Pharmaceuticals
―
Best Analysts Covering LIPO
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-36.57%
reiterated a buy rating 8 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -36.57% per trade.
---